BackBristol-Myers Squibb Overview

Bristol-Myers Squibb Goodwill

Track Bristol-Myers Squibb's goodwill ($22B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$21.74B
0.01% YoYΔ $3.00M vs prior year quarter

Peer average

Loading

Bristol-Myers Squibb Goodwill History

Loading

Bristol-Myers Squibb vs. peers: Goodwill Comparison

Loading

Bristol-Myers Squibb Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bristol-Myers Squibb (BMY) FAQ

The latest goodwill for BMY is $22B as of March 2026. That compares with $22B in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Bristol-Myers Squibb's historical trend and sector peers before judging valuation or financial health.

Over the past year, BMY's goodwill moved from $22B to $22B — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bristol-Myers Squibb's operating scale or balance-sheet position.

A goodwill figure of $22B for BMY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BMY's goodwill ($22B), review year-over-year change from $22B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Bristol-Myers Squibb's goodwill against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.